The Diagnostic Power Of Coronary CT Angiography In Patients With Chest Pain And Zero Calcium Score

August 10, 2024 updated by: Mohammed Abdellah Farrag Abdelrheim, Assiut University

The Diagnostic Power Of Coronary Ct Angiography In Patients With Chest Pain And Zero Calcium Score

To prove the non-used wide diagnostic range of CCTA in diagnosis of other causes of chest pain in addition to the traditional known role in coronary atherosclerosis.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The heart is a specialized muscular organ which receives blood via major veins) SVC, IVC ,CS( then pumps it through the arteries (Aorta and Pulmonary artery) towards the systemic and pulmonary circulations. Non oxygenated blood enters the heart via SVC, IVC and CS, passes to the lungs to be oxygenated via the Pulmonary artery then returns to the heart via the Pulmonary veins and finally to the systemic circulation through Aorta.

Cardiac muscles are unique and differs from skeletal and smooth muscles to suit their function, and they are not liable to regenerate like all cells in the body, the cardiac muscles needs to be supplied with oxygen, nutrients and their metabolic wastes must be drained away. This is achieved by the coronary circulation which formed of two main arteries that arise just above the aortic valve, These are the right and left main coronary arteries and their branches. the venous drainage is through the major cardiac veins towards CS that finally drains at the right atrium. [1] As a result any affection of coronary arteries or interruption of blood flow inside it will cause weakness or death of cardiac cells (myocardium).The diseases affecting coronary arteries may be congenital e.g. abnormal course of the coronary arteries or myocardial bridge , traumatic e.g. dissection, inflammatory e.g. Takayasu's arteritis (TAK) , vascular e.g. aneurysm, lastly and the most common is atherosclerosis. [2] Atherosclerosis causes variable degrees of occlusion of the coronary arteries and results in a demand-supply mismatch of oxygen. it typically involves the formation of plaques in the arterial lumen of that impedes blood flow, atherosclerosis may be diffuse (mild subintimal affection), focal or multifocal called atherosclerotic plaques. Plaque is a build-up of fatty material that narrows the vessel lumen and impedes the blood flow, (fatty streak) Which is formed by subendothelial deposition of lipid-laden macrophages (foam cells), smooth muscles and collagen. Over time, this plaque could grow in size or become stable if no further insult occurs to the endothelium. If it becomes stable, a fibrous cap will form, and the lesion will become calcified over time. The drawback of calcified plaque is stenosis that impedes the blood supply while that of soft plaque is liability to further growth, detachment causing arterial occlusion or external rupture causing hemopericardium. [3] So that it is an advantage of CT over coronary catheterization extra coronary lesions either vascular e.g. aortic dissection, pulmonary embolism, cardiac e.g. pericarditis, extracardiac and mediastinal e.g. GERD, or even pleurisy, myositis and other chest pathologies via large FOV scanning through another phase. Cardiovascular diseases do not frequently have symptoms but may cause chest pain which is the most important symptom in CVDs, and may be a sign of other diseases like vascular, inflammatory …etc.

In the past CADs diagnosis could be done by many tests like ECG, blood tests, Cardiac catheterization and angiogram Which is invasive despite of high real time value and ability to place a stent or balloon dilatation. [4] Recently multidetector computed tomography (CT) and CT angiography could be done due to recent equipment that could match the cardiac motion and avoid the artifacts .

A CT scan of the heart can show calcium deposits and blockages in the coronary arteries and be calculated by calcium score, The calcium score is calculated based on the amount of calcification in the vessel walls of coronary arteries observed in a cardiac (CT) scan, Many methods have been used in calcium scoring e.g. Agatston calcium score which is the most popular one. A higher score indicates a larger amount of calcium deposition. However; Ca score of zero is not a sign of negative CVDs, so that CCTA become a must and don't just depend on the coronary Ca score alone.

A CT coronary angiogram is mainly used to check for narrowed or blocked coronary artery by any plaque even the soft non calcified ones . However, it can check for other heart conditions such congenital heart disease, valvular heart disease, carditis, aortic aneurysms…etc.

A CT coronary angiogram differs from a standard coronary angiogram. Which is an invasive technique that could only see the lumen of the artery not the wall itself and calcium score is not available, yet still a real time technique and have a therapeutic value at the same time. [5]

Study Type

Observational

Enrollment (Estimated)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: hamdy M ibrahim, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

  • community sample
  • primary care clinic

Description

Inclusion Criteria:

  • patients with chest pain whom are referred by cardiologist for coronary CT angiography and coronary artery calcium score to detect atherosclerosis .

Exclusion Criteria:

  • Patients who refuse to sign the consent
  • Subjects suspected of having myocardial infarction, unstable angina pectoris, or coronary artery disease
  • Subjects who experienced heart attack within 40 days prior to the CT scan
  • Subjects with a diagnosed complicated heart anomaly
  • BMI > 35 kg/m2
  • Serum creatinine ≥ 1.5 mg/dl
  • Pregnant subjects
  • Subjects with a history of hypersensitivity reaction to contrast agents
  • Subjects with contraindications to the use of nitroglycerine
  • Subjects who plan to participate or enroll in other randomized clinical trials for cardiovascular disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate outcome of coronary CT angiography in cases with chest pain with zero calcium score . Evaluate outcome of coronary CT angiography in cases with chest pain with zero calcium score . Evaluate outcome of coronary CT angiography
Time Frame: two years
Evaluate outcome of coronary CT angiography in cases with chest pain with zero calcium score
two years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

August 10, 2024

First Submitted That Met QC Criteria

August 10, 2024

First Posted (Actual)

August 14, 2024

Study Record Updates

Last Update Posted (Actual)

August 14, 2024

Last Update Submitted That Met QC Criteria

August 10, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Coronary CT Angiography

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on CT - Coronary Thrombosis

Clinical Trials on CCTA

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe